Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$111.03
-38.56% vs spot
Sell
Spot price
$180.71
Mkt cap $8.7B
subtle cardAnalyst PT consensus
$205.43
+13.68% vs spot
subtle cardMethods covered
12 / 13
11 in blend
subtle cardFootball field
CRL · fair-value range by method
Method comparison
CRL · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| DCF · FCFF | dcf | $99.72 | $122.86 – $165.12 | -44.82% | 26.5% | WACC 7.3%, g₀=-5.0%, gₗ=2.0% | high |
| DCF · FCFE | dcf | $78.50 | $93.57 – $99.51 | -56.56% | 19.9% | kₑ 10.9%, g₀=-5.0%, gₗ=2.0% | high |
| Residual income | income | $49.16 | $43.26 – $55.06 | -72.80% | 13.2% | BV 70.94, ROE -4.5% → kₑ | low |
| EVA / MVA | income | $54.68 | $48.12 – $61.24 | -69.74% | 9.3% | IC 6.1B, WACC 7.3% | high |
| Justified P/B | multiple | $2.25 | $1.91 – $2.59 | -98.75% | 6.6% | Fair P/B 0.03 · ROE -4.5%, kₑ 10.9% | low |
| P/S · sector | multiple | $354.83 | $301.61 – $408.05 | +96.35% | 4.0% | Rev/sh 88.71 × peer P/S 4.00 | med |
| EV / EBITDA | multiple | $238.94 | $210.26 – $267.61 | +32.22% | 13.2% | EBITDA × peer 15.0× − ND 2.9B | high |
| EV / EBIT | multiple | $138.94 | $118.10 – $159.79 | -23.11% | 2.6% | EBIT × peer 18.0× − ND | med |
| EV / Sales | multiple | $238.61 | $202.81 – $274.40 | +32.04% | 2.6% | Sales × peer 3.40× − ND | med |
| Earnings power | intrinsic | $90.97 | $80.06 – $101.89 | -49.66% | 0.7% | NOPAT / WACC, no growth | med |
| Book NAV | asset | $70.94 | $67.39 – $74.49 | -60.74% | 1.3% | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | $25.07 | $21.31 – $28.83 | -86.13% | — | Cash 100% + non-cash 70% − Liab. | low |
| Reverse DCF | reverse | — | — | — | — | Implied g 5.4% · Conservative — modest implied growth | high |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (1.45)β | × 1.45 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 10.91% |
| Pre-tax cost of debtkd | 3.49% |
| Effective tax ratet | 0.0% |
| After-tax cost of debt | 3.49% |
| Equity weight$3.2B | 51.2% |
| Debt weight$3.1B | 48.8% |
| WACC | 7.29% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | -4.17% |
| Analyst forward EPS growthFMP | — |
| Historical 5y revenue CAGRFY | 3.20% |
| Historical 5y EPS CAGRFY | -70.26% |
| Sustainable g (ROE × retention)Δ | -4.49% |
| Blended near-term growth (g₀) | -5.00% |
| Terminal growth (gₗ) | 2.00% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2023-12-27)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Healthcare (live sector PE unavailable)
- FMP /price-target-consensus— mean $205.43
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.